Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Pediatrics/Neonatology | Genetic Disease | Neurology

Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 Last 

California

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Sacramento California 95817

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Georgia

UPDATED

Atlanta Georgia 30322

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Decatur Georgia 30033

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Decatur Georgia 30033

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Kansas

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Maryland

Baltimore Maryland 21205

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Massachusetts

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Cambridge Massachusetts

Patients are needed to participate in a clinical research study evaluating agalsidase beta for the treatment of Fabry Disease

Cambridge Massachusetts 02142

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Michigan

Grand Rapids Michigan 49525

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

New York

New York New York 10016

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

North Carolina

Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Ohio

Cincinnati Ohio 45229-3039

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Columbus Ohio 43212

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Pennsylvania

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Texas

Baylor Research Institute
Dallas Texas 75204

A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

View More ▼

Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Virginia

UPDATED

Fairfax Virginia 22030

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Washington

Seattle Washington 98195-6320

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Wisconsin

Milwaukee Wisconsin 532261

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Austria

UPDATED

Graz A-8036

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Croatia

UPDATED

Zagreb 10000

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Czech Republic

UPDATED

Praha 2 12808

A clinical research study of GZ402671 for the treatment of Fabry's Disease

France

UPDATED

Lyon F-69003

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Georgia

UPDATED

Tblisi 0179

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Germany

UPDATED

Bayreuth 95445

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Berlin D-12200

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Celle 29223

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Chemnitz 09131

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Dresden 01307

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

View More ▼

UPDATED

Duesseldorf D-40225

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Giessen D-35385

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Hamburg 20246

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Jena 07740

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Leipzig 04103

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Mühlhausen / Thürigen 99974

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

München D-81377

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Tuebingen 72076

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

UPDATED

Ulm D-89081

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Poland

UPDATED

Warsaw 02-957

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

First 1 2 3 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.